129 related articles for article (PubMed ID: 27424359)
1. Anti-Müllerian Hormone in Patients Treated with Chemotherapy for Gestational Trophoblastic Neoplasia Does Not Predict Short-Term Fertility.
Ghorani E; Ramaswami R; Smith RJ; Savage PM; Seckl MJ
J Reprod Med; 2016; 61(5-6):205-9. PubMed ID: 27424359
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
[TBL] [Abstract][Full Text] [Related]
3. A prospective cohort study with serum anti-mullerian hormone levels change in patients undergoing uterine preservation after gestational trophoblastic neoplasia treatment with a methotrexate regimen.
Tuan Dat D; Huyen Thuong PT; Hong Hai D; Khac Toan N; Tai Duc N; Duy Anh N; Thi Thu Ha N
Clin Ter; 2024; 175(2):128-134. PubMed ID: 38571471
[TBL] [Abstract][Full Text] [Related]
4. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
5. Anti-Müllerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review.
Iwase A; Nakamura T; Nakahara T; Goto M; Kikkawa F
Reprod Sci; 2015 May; 22(5):519-26. PubMed ID: 25228631
[TBL] [Abstract][Full Text] [Related]
6. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L
Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773
[TBL] [Abstract][Full Text] [Related]
7. Review of clinical indicators, including serum anti-Müllerian hormone levels, for identification of women who should consider egg freezing.
Martyn F; O'Brien YM; Wingfield M
Int J Gynaecol Obstet; 2017 Jul; 138(1):37-41. PubMed ID: 28378324
[TBL] [Abstract][Full Text] [Related]
8. Anti-Müllerian hormone as a predictor of reproductive potential.
Hawkins Bressler L; Steiner A
Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):385-390. PubMed ID: 30299431
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the multiples of the median of serum anti-müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case-control study.
Lai THT; Lau LSK; Ngu SF; Chu MYM; Chan KKL; Ng EHY; Ngan HYS; Li RHW; Tse KY
Cancer Med; 2024 Apr; 13(7):e7134. PubMed ID: 38545760
[TBL] [Abstract][Full Text] [Related]
10. Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis?
Stochino-Loi E; Darwish B; Mircea O; Touleimat S; Millochau JC; Abo C; Angioni S; Roman H
Fertil Steril; 2017 Mar; 107(3):707-713.e3. PubMed ID: 28089574
[TBL] [Abstract][Full Text] [Related]
11. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study.
Kato N; Iwase A; Sugita A; Goto M; Nakahara T; Nakamura T; Kondo M; Osuka S; Mori M; Saito A; Kikkawa F
Gynecol Endocrinol; 2015 Jan; 31(1):22-5. PubMed ID: 25030844
[TBL] [Abstract][Full Text] [Related]
13. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
[TBL] [Abstract][Full Text] [Related]
14. [Does the serum AMH assay allow predicting reliably female fertility?].
Rolland AL; Dewailly D
Gynecol Obstet Fertil; 2015 Oct; 43(10):670-5. PubMed ID: 26388252
[TBL] [Abstract][Full Text] [Related]
15. Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer Treatment.
Rodgers RJ; Abbott JA; Walters KA; Ledger WL
Front Endocrinol (Lausanne); 2021; 12():689532. PubMed ID: 34557157
[TBL] [Abstract][Full Text] [Related]
16. [Level of AMH as a predictor of the result of ovarian stimulation].
Vrublovský P
Ceska Gynekol; 2016 Jan; 81(1):23-6. PubMed ID: 26982060
[TBL] [Abstract][Full Text] [Related]
17. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-Müllerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis.
Thöne J; Kollar S; Nousome D; Ellrichmann G; Kleiter I; Gold R; Hellwig K
Mult Scler; 2015 Jan; 21(1):41-7. PubMed ID: 25145691
[TBL] [Abstract][Full Text] [Related]
19. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women.
Pearce K; Gleeson K; Tremellen K
Hum Reprod; 2015 Sep; 30(9):2171-7. PubMed ID: 26202912
[TBL] [Abstract][Full Text] [Related]
20. An assessment of anti-Müllerian hormone in predicting mating outcomes in female hamsters that have undergone natural and chemically-accelerated reproductive aging.
Roosa KA; Zysling DA; Place NJ
Gen Comp Endocrinol; 2015 Apr; 214():56-61. PubMed ID: 25801548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
